Literature DB >> 2043752

Solution structure of salmon calcitonin.

J P Meyer1, J T Pelton, J Hoflack, V Saudek.   

Abstract

Salmon calcitonin, a 32-residue peptide with a 1-7 disulfide bridge, was synthesized by standard solid-phase techniques, and studied by CD and two-dimensional NMR experiments. The peptide was dissolved in pure trifluoroethanol (TFE) and in aqueous solutions containing various amounts of TFE. CD studies in pure TFE indicated the presence of an alpha-helical structure comprising 40% of the constituent amino acids. This was fully confirmed by nmr. A detailed analysis was performed with the peptide in a 9 : 1 deuterated TFE/H2O mixture. A total of 365 nuclear Overhauser enhancements (154 intraresidual, 112 sequential and 99 long range) were complied from the nuclear Overhauser enhancement spectroscopy spectra and used in the distance geometry calculations. The core of the peptide between residues 8 and 22 assumes an alpha-helix like structure. The Cys 1-Cys 7 ring is well defined and in close association with the helix, while the C-terminal decapeptide folds back toward the core, forming a loose loop.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043752     DOI: 10.1002/bip.360310210

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  11 in total

1.  Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.

Authors:  P Amodeo; A Motta; G Strazzullo; M A Castiglione Morelli
Journal:  J Biomol NMR       Date:  1999-02       Impact factor: 2.835

2.  Dynamic properties of salmon calcitonin bound to sodium dodecyl sulfate micelles: a restrained molecular dynamics study from NMR data.

Authors:  M A Castiglione Morelli; A Pastore; A Motta
Journal:  J Biomol NMR       Date:  1992-07       Impact factor: 2.835

3.  Solution state structures of human pancreatic amylin and pramlintide.

Authors:  John R Cort; Zhihong Liu; Gregory M Lee; K N L Huggins; Susan Janes; Kathryn Prickett; Niels H Andersen
Journal:  Protein Eng Des Sel       Date:  2009-07-12       Impact factor: 1.650

4.  Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.

Authors:  Kian Kamgar-Parsi; Liu Hong; Akira Naito; Charles L Brooks; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

5.  Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.

Authors:  M Kamihira; A Naito; S Tuzi; A Y Nosaka; H Saitô
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

6.  Synthesis, characterization and biodistribution studies of (125)I-radioiodinated di-PEGylated bone targeting salmon calcitonin analogue in healthy rats.

Authors:  Yang Yang; Krishna H Bhandari; Arash Panahifar; Michael R Doschak
Journal:  Pharm Res       Date:  2013-12-20       Impact factor: 4.200

7.  Thermosensitive drug delivery system of salmon calcitonin: in vitro release, in vivo absorption, bioactivity and therapeutic efficacies.

Authors:  Yu Tang; Jagdish Singh
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

8.  Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography.

Authors:  Eva Johansson; Jakob Lerche Hansen; Ann Maria Kruse Hansen; Allan Christian Shaw; Peter Becker; Lauge Schäffer; Steffen Reedtz-Runge
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

9.  Design and Characterization of Chemically Stabilized Aβ42 Oligomers.

Authors:  Ghiam Yamin; Tien-Phat Vuong Huynh; David B Teplow
Journal:  Biochemistry       Date:  2015-08-18       Impact factor: 3.162

10.  Adsorption of salmon calcitonin to PLGA microspheres.

Authors:  S Calis; R Jeyanthi; T Tsai; R C Mehta; P P DeLuca
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.